Logo image of SLXN

SILEXION THERAPEUTICS CORP (SLXN) Stock Analyst Earnings Estimates

NASDAQ:SLXN - Nasdaq - KYG1281K1224 - Common Stock - Currency: USD

8.58  +0.27 (+3.24%)

After market: 8.59 +0.01 (+0.12%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
SLXN revenue by date.SLXN revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
SLXN ebitda by date.SLXN ebitda by date.
N/AN/AN/A-6M-12.546M
-109.09%		N/AN/AN/A
EBIT
YoY % growth
SLXN ebit by date.SLXN ebit by date.
-200K-770K
-285.00%		-1.11M
-44.16%		-6.045M
-444.63%		-12.571M
-107.94%		N/A
40.07%		N/A
-34.55%		N/A
-28.80%
Operating Margin
SLXN operating margin by date.SLXN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SLXN eps by date.SLXN eps by date.
N/AN/AN/AN/AN/AN/A
91.50%		N/A
-36.46%		N/A
-29.01%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-3.67-3.83
-88.42%		-0.26
99.92%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-1.815M
-876.11%		-1.97M
75.49%		-2.068M
-8.82%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 -3.90 -3.37-0.53-15.86%
Q4 2024
Q2Q % growth		 -311.40 -14.99-296.41-1,976.83%
SLXN Yearly EPS VS EstimatesSLXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1400% -1400% 0% 0%
RevenueN/A N/A N/A N/A